washington post glp 1 What Ozempic and other GLP-1 weight loss drugs do the body GLP-1 weight-loss treatment is being

The precision obesity medicine market is projected to reach USD 4.8 billion by 2032

Addiction potential of phentermine prescribed during long-term treatment of obesity

Side Effects and Safety Sermorelin carries a favorable safety profile relative to direct HGH therapy

Hims & Hers Health reported first-quarter 2026 results with revenue of US$608.1 million, up from US$586.01 million a year earlier, but moved from net income of US$49.49 million to a net loss of US$92.12 million as earnings per share turned from profit to a US$0.40 loss

2 Initially approved for the treatment of advanced or unresectable melanoma, Keytruda received its 40th FDA indication approval on June 17, 2024, with the most recent approval covering endometrial cancer

Telehealth Weight Loss Program Explained What Measured Shows Before Intake vs What Resolves Later 4